630 related articles for article (PubMed ID: 20674506)
21. [Scleroderma and alveolar inflammation].
Crestani B; Aubier M
Rev Mal Respir; 1996; 13(1):15-20. PubMed ID: 8650411
[TBL] [Abstract][Full Text] [Related]
22. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
[TBL] [Abstract][Full Text] [Related]
23. [Immunological status of alveolar macrophages in patients with lung cancer and benign pulmonary diseases].
Liu C
Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):408-11, 446. PubMed ID: 1330230
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory and fibrotic mediator release by alveolar macrophages from coal miners.
Kuhn DC; Stauffer JL; Gaydos LJ; Demers LM
J Toxicol Environ Health; 1995 Sep; 46(1):9-21. PubMed ID: 7666496
[TBL] [Abstract][Full Text] [Related]
25. Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fibre exposed human alveolar macrophages.
Drumm K; Buhl R; Kienast K
Eur J Med Res; 1999 Feb; 4(2):59-66. PubMed ID: 10066641
[TBL] [Abstract][Full Text] [Related]
26. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
27. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.
Oltmanns U; Schmidt B; Hoernig S; Witt C; John M
Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045
[TBL] [Abstract][Full Text] [Related]
28. TNF alpha mRNA, but not IL-1 beta, is differentially expressed in lung macrophages of patients with active pulmonary sarcoidosis.
Kaneshima H; Nagai S; Shimoji T; Tsutsumi T; Mikuniya T; Satake N; Izumi T
Sarcoidosis; 1994 Mar; 11(1):19-25. PubMed ID: 8036337
[TBL] [Abstract][Full Text] [Related]
29. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes.
Rosseau S; Hammerl P; Maus U; Günther A; Seeger W; Grimminger F; Lohmeyer J
J Immunol; 1999 Oct; 163(8):4495-502. PubMed ID: 10510392
[TBL] [Abstract][Full Text] [Related]
30. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern.
Kodelja V; Müller C; Politz O; Hakij N; Orfanos CE; Goerdt S
J Immunol; 1998 Feb; 160(3):1411-8. PubMed ID: 9570561
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis.
Ziegenhagen MW; Schrum S; Zissel G; Zipfel PF; Schlaak M; Müller-Quernheim J
J Investig Med; 1998 Jun; 46(5):223-31. PubMed ID: 9676055
[TBL] [Abstract][Full Text] [Related]
32. Modulation of chitotriosidase during macrophage differentiation.
Di Rosa M; Malaguarnera G; De Gregorio C; D'Amico F; Mazzarino MC; Malaguarnera L
Cell Biochem Biophys; 2013 Jun; 66(2):239-47. PubMed ID: 23152091
[TBL] [Abstract][Full Text] [Related]
33. Systemic chemotherapy alters interleukin-1 beta and its receptor antagonist production by human alveolar macrophages in lung cancer patients.
Haku T; Yanagawa H; Ohmoto Y; Takeuchi E; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Sone S
Oncol Res; 1996; 8(12):519-26. PubMed ID: 9160356
[TBL] [Abstract][Full Text] [Related]
34. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M
PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260
[TBL] [Abstract][Full Text] [Related]
35. Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis.
Tao B; Jin W; Xu J; Liang Z; Yao J; Zhang Y; Wang K; Cheng H; Zhang X; Ke Y
J Immunol; 2014 Sep; 193(6):2801-11. PubMed ID: 25127857
[TBL] [Abstract][Full Text] [Related]
36. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8.
Lynch JP; Standiford TJ; Rolfe MW; Kunkel SL; Strieter RM
Am Rev Respir Dis; 1992 Jun; 145(6):1433-9. PubMed ID: 1596015
[TBL] [Abstract][Full Text] [Related]
37. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease.
Janson RW; King TE; Hance KR; Arend WP
Am Rev Respir Dis; 1993 Aug; 148(2):495-503. PubMed ID: 8342915
[TBL] [Abstract][Full Text] [Related]
38. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact.
Fireman E; Ben-Efraim S; Spinrad S; Topilsky M; Greif J
Eur Respir J; 1993 Jul; 6(7):956-64. PubMed ID: 8370444
[TBL] [Abstract][Full Text] [Related]
39. Increased production of matrix metalloproteinase-2 in alveolar macrophages and regulation by interleukin-10 in patients with acute pulmonary sarcoidosis.
John M; Oltmanns U; Fietze I; Witt C; Jung K
Exp Lung Res; 2002; 28(1):55-68. PubMed ID: 11792075
[TBL] [Abstract][Full Text] [Related]
40. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
